This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Business - MarketWatch - 7 hours ago

Small-cap biotech Jaguar Health’s stock jumps as it launches treatment for a painful side effect of cancer treatment

The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...

Business - MarketWatch - October 16

Bipolar disorder: how lithium as a treatment fell out of favour

As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition. Occupational stress ...

World - The Guardian - 5 days ago

Vietnam waits for major upgrade to its $200 billion stock market

Vietnam's chip capabilities have it competing against near neighbor Malaysia, attracting global semiconductor firms.

Business - CNBC - October 28

Biotech stock tumbles after unexplained 1,446% gain

Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise.

Business - MarketWatch - October 16

Sage Therapeutics’ stock falls 4.7% as biotech unveils plan to cut 33% of workforce

More than 165 jobs to go as company seeks to extend cash runway and focus on postpartum drug launch.

Business - MarketWatch - October 17

Icahn Enterprises’ stock slides 14% as majority-owned CVR Energy suspends its dividend

Icahn Enterprises LP’s stock fell 4% early Tuesday, after CVR Energy Inc., in which it owns a 66% stake, said it would suspend its third-quarter dividend, as unplanned outages and a weak macro ...

Business - MarketWatch - October 29

People with depression could administer brain stimulation at home, trial shows

Findings from phase two trial suggest patients could receive treatment without having to attend a clinic. People with major depression could alleviate their symptoms by self-administering a form of ...

World - The Guardian - October 21

What to know about a tropical depression that could develop into a late-season storm

Meteorologist Stephanie Abrams with The Weather Channel gives an update on Tropical Depression 19 in the Caribbean, which could develop into a late-season storm that impacts Florida.

Biogen’s stock hit by soft sales of Alzheimer’s treatment

“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.

Business - MarketWatch - October 30

Disney is doubling its fleet of cruise ships. What that says about the company's strategy

As the future clouds for Walt Disney Co.'s lucrative theme parks business, one bright spot continues to be its cruise line.

Entertainment - Los Angeles Times - October 23

Could Reiki therapy help with breast cancer treatments?

Treatments like chemotherapy and radiation are critical for patients fighting breast cancer, now new research is looking at how one mind-body therapy could help. CBS News' Jarred Hill has more.

Russia Could Expand Its Assistance to Houthis, U.S. Says

The group’s attacks in the Red Sea have driven up shipping costs and forced the United States and its allies to increase their naval presence in the region.

World - The New York Times - October 25

Catherine joins royals at first major event since finishing treatment

The Princess of Wales has joined the rest of the Royal Family at the Festival of Remembrance in London's Royal Albert Hall.

Princess Kate makes first major public appearance since cancer treatment

Catherine Kate, the Princess of Wales, attended a memorial service for Britain's military veterans over the weekend. This was her first high-profile event since ending cancer treatment earlier this ...

These stocks could benefit from Trump’s election victory, B. Riley says

Trump’s victory could benefit a host of stocks from sectors such as coal mining, fintech, cryptocurrency and for-profit education, says B. Riley Securities.

Business - MarketWatch - November 6

Clear link between online posts and violent disorder, says watchdog

Regulator says misinformation spread widely and quickly and the response of big tech was "uneven".

Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin

Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin.

Business - MarketWatch - November 7

American to pay $50 million fine for its treatment of disabled passengers

Airlines must be accountable for their treatment of passengers with disabilities, Transportation Secretary Pete Buttigieg said.

How losing your sense of smell affects breathing patterns and mental health

Losing or not having your sense of smell may be linked to changes in breathing that could lead to depression, social isolation or other mental health problems, a new study suggests.

Lucy had postnatal depression and ended her life - could more have been done?

The family of a woman who ended her life while suffering postnatal depression say she was let down.

‘Exciting’ new lupus treatment could end need for lifelong medication

CAR T-cell genetic therapy, typically used in cancer patients, could lead to cure for the disease, says expert. Doctors are hailing a “groundbreaking” new treatment for lupus that genetically ...

World - The Guardian - 6 days ago

Amazon’s satellite constellation doesn’t offer its stock much upside, says BofA

The company’s ambitious Project Kuiper broadband satellite system has been attracting a lot of attention recently.

Business - MarketWatch - October 21

Super Micro still can’t say when it will file annual report, and its stock drops

Server maker doesn’t expect its accounting issues to impact its ability to serve customers

Business - MarketWatch - November 6

Arm says it’s fueling many AI needs, but its stock shrugs off an earnings beat

The chip designer beat expectations for both its revenue segments.

Business - MarketWatch - November 7

Starbucks turnaround plan has ‘merit’ but its unknown cost makes the stock a ‘sell,’ analyst says

Redburn Atlantic’s Edward Lewis downgrades coffee-shop giant after new Chief Executive Brian Niccol unveils his “Back to Starbucks” plan.

Business - MarketWatch - Yesterday

Tesla should sell its stock after the big post-election run up, analyst says

Tesla should take advantage of its stock’s post-election surge to raise capital by selling shares, a Jefferies analyst says.

Business - MarketWatch - 1 hour ago

Nvidia doubles down on India with Hindi language model and major partnerships

Nvidia on Thursday announced a slew of partnerships with major Indian firms and launched a Hindi language model.

Business - CNBC - October 24

Starbucks’ new CEO has diagnosed its problems. Analysts say the solutions could get expensive.

Starbucks CEO Brian Niccol has laid out a bold turnaround plan for the coffee chain, with plans to tighten up service and redesign stores. But analysts are proceeding with caution.

Business - MarketWatch - November 1

FirstFT: Japan plunges into political chaos

Also in today’s newsletter, oil price falls and Franklin Templeton hit by record outflows

World - Financial Times - October 28

‘FOMO’ could help drive stocks higher after the election, one top Goldman Sachs strategist says

The upcoming U.S. election has helped inspire a sense of foreboding on Wall Street, judging by the still-elevated level of the Cboe Volatility Index, otherwise known as the VIX or the stock ...

Business - MarketWatch - October 28

HRT should be first-line menopause treatment, NICE says

Information on the menopause drugs' benefits and risks have been included in updated guidance.

Perplexity AI Hopes to Double Its Valuation to $8 Billion

The Jeff Bezos-backed AI company is looking to raise around $500 million in its new funding round.

Business - Inc. - October 20

Latest in This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho